Newsletter - All News

Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research

Category
Continent
From
To
 
Merck announces positive results from phase 3 STRI...

Merck announces positive results from phase 3 STRI...

Category : Clinical Trial Update 12 September 2025

"Merck, known as MSD outside of the United States and Canada, announced positive results from t...
Scipher Medicine Enters into Partnership with Maxy...

Scipher Medicine Enters into Partnership with Maxy...

Category : Licensing/Collaboration Deal 12 September 2025

"Scipher Medicine has entered into a strategic collaboration with Maxymune Therapeutics. ...
Teva’s Emrusolmin Receives U.S. FDA Fast Track Des...

Teva’s Emrusolmin Receives U.S. FDA Fast Track Des...

Category : ODD/BTA/FTA Status 12 September 2025

"Teva Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has grante...
Alchemab initiates phase 1 trial of ATLX-1282 and...

Alchemab initiates phase 1 trial of ATLX-1282 and...

Category : Clinical Trial Update 11 September 2025

"Alchemab Therapeutics (Alchemab), a biopharmaceutical company which identifies and develops na...
US FDA accepts BLA for Sobi's Nanoecapsulated Siro...

US FDA accepts BLA for Sobi's Nanoecapsulated Siro...

Category : Approval/Launch 11 September 2025

"Sobi, a global biopharmaceutical company dedicated to delivering innovative treatments for pat...

Categories

Latest Newsletter Post

Subscribe to Our Newsletter!

Subscribe to get latest updates and information.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!